Intranasal influenza vaccine spurs strong immune response in Phase 1 study
2021-02-03
(Press-News.org) WHAT:
An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation. The investigational vaccine, called Ad4-H5-VTN, is a recombinant, replicating adenovirus vaccine designed to spur antibodies to hemagglutinin, a protein found on the surface of influenza viruses that attaches to human cells.
The investigational vaccine was developed by Emergent Biosolutions Inc., (Gaithersburg, Maryland). It was administered intranasally (28 study participants), as an oral capsule (10 participants) and via a tonsillar swab (25 participants) to healthy men and non-pregnant women ages 18 to 49 years.
The participants who received the vaccine intranasally or via tonsillar swab showed significantly higher H5-specific neutralizing antibody levels compared to the group receiving the vaccine capsule orally. The participants who received the intranasal vaccine shed viral DNA for two-to-four weeks, but virus could be cultured for a median of only one day. Participants had evidence of H5-specific CD4+ and CD8+ T-cell responses. Additionally, volunteers who received the intranasal vaccine had high levels of serum neutralizing antibodies at 26 weeks after vaccination, and this level was unchanged at three to five years after a single intranasal dose of the vaccine. The duration of viral shedding correlated with a high magnitude of neutralizing antibody response at week 26. In addition, the intranasal vaccine induced a mucosal antibody response in the nose, mouth, and rectum.
The study authors speculate that replication-competent vector vaccines may have advantages over other types of vaccines because they can express viral proteins at higher levels and for longer durations. Additionally, this type of vaccine induces a mucosal immune response that is critical for limiting transmission of viruses that infect mucosal tissues.
The vaccine platform could be highly adaptable for use against other viruses including HIV and SARS-CoV-2, according to the authors.
INFORMATION:
ARTICLE:
K Matsuda et al. A Replication Competent Adenovirus-Vectored Influenza Vaccine Induces Durable Systemic and Mucosal Immunity. Journal of Clinical Investigation DOI: 10.1172/JCI140794 (2021).
WHO:
Mark Connors, M.D., chief of the HIV-specific Immunity Section in NIAID's Laboratory of Immunoregulation and principal investigator for the Phase 1 study, is available for interviews.
CONTACT:
To schedule interviews, please contact NIAID News Office, (301) 402-1663, niaidnews.niaid.nih.gov.
NIAID conducts and supports research--at NIH, throughout the United States, and worldwide--to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
NIH...Turning Discovery Into Health®
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-03
BATON ROUGE, LOUISIANA - In patients with type 2 diabetes, big swings in blood sugar levels between doctors' visits are associated with an increased risk of heart disease.
The study, published in the journal Diabetes, Obesity & Metabolism, looked at more than 29,000 patients with type 2 diabetes over a two-year period. Patients who already had heart disease were excluded.
The American Diabetes Association recommends adults with diabetes maintain an A1c, the average blood sugar level over the past two to three months, of less than 7 percent to reduce complications from diabetes, such ...
2021-02-03
A study published in the journal Applied Ergonomics compared the standardised processes set out for community pharmacists to follow when dispending medication to what happens in reality. A gap was revealed and researchers also looked at the reasons for this.
The research, "Mind the gap: Examining work-as-imagined and work-as-done when dispensing medication in the community pharmacy setting"*, was conducted by the National Institute for Health Research Greater Manchester Patient Safety Translational Research Centre (NIHR GM PSTRC). The Centre is a partnership between The University of Manchester and Salford Royal NHS Foundation Trust.
The research involved observing pharmacists and pharmacy staff as they conducted the task of dispensing, ...
2021-02-03
Sneakers can be about style, history and even community. A new study reveals that for "Sneakerheads," sneakers are an important facet of their identities, particularly for African-American men who grew up in the 1970s and '80s coveting sneakers popularized by hip-hop stars and basketball legends.
In the journal Fashion and Textiles, researchers report new insights into the motivations, brand preferences and identity considerations of Sneakerheads. The findings were drawn from interviews with 12 men in the mid-Atlantic region of the United States, many whom are African-American, and ...
2021-02-03
Researchers have developed a computerized adaptive screener to identify youth at risk for attempting suicide. The screener, called the computerized adaptive screen for suicidal youth (CASSY), consists of 11 questions on average and correctly identified 82.4% of youth who went on to attempt suicide in the three months following screening. The results suggest this screener could serve as an easy-to-use way for providers to detect youth suicide risk in emergency department settings. The findings, funded by the National Institute of Mental Health (NIMH), ...
2021-02-03
Today, neuroscience and robotics are developing hand in hand. Mikhail Lebedev, Academic Supervisor at HSE University's Centre for Bioelectric Interfaces, spoke about how studying the brain inspires the development of robots.
Robots are interesting to neuroscience and neuroscience is interesting to robots - this is what the article 'Neuroengineering challenges of fusing robotics and neuroscience' was about in the journal Science Robotics. Such collaborative development contributes to progress in both fields, bringing us closer to developing more advanced android robots and a deeper understanding ...
2021-02-03
Among the many avenues that viruses can use to infect humans, drinking water may pose only a tiny risk for spreading certain viruses like the novel coronavirus. However, in cases where there is unauthorized wastewater disposal or other events of inadvertent mixing of wastewater with water sources, the possibility of transmission through drinking water remains unknown.
Using a surrogate of the coronavirus that only infects bacteria, researchers at Texas A&M University have now presented strong evidence that existing water purification plants can easily reduce vast quantities of the virus thereby protecting our household water from such contagions. In particular, the researchers showed that the water purification step called coagulation could alone get rid of 99.999% of ...
2021-02-03
The economic value of insect pollinators was $34 billion in the U.S. in 2012, much higher than previously thought, according to researchers at the University of Pittsburgh and Penn State University. The team also found that areas that are economically most reliant on insect pollinators are the same areas where pollinator habitat and forage quality are poor.
"Pollinators like bees play an extremely important role in agriculture," explained senior author Vikas Khanna, Wellington C. Carl Faculty Fellow and associate professor of civil and environmental engineering at Pitt's Swanson School of Engineering. "The insects that pollinate farmers' crops underpin our ecosystem biodiversity and function, ...
2021-02-03
BOSTON - Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
"In patients critically ill with COVID-19, therapeutic dose anticoagulation started early in the ICU stay was not associated with improved survival,"says Hanny Al-Samkari, MD, an investigator in the Division of Hematology/Oncology at Massachusetts General Hospital (MGH) and lead author ...
2021-02-03
Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers.
The findings, based on an analysis of all US COVID-19 treatment trials registered on ClinicalTrials.gov, were published Jan. 27 in the Journal of General Internal Medicine.
"This study highlights the blind spot in how clinical trials are done in the United States," said senior author Neda Laiteerapong, MD, MS, a general internist and associate director of the Center for Chronic Disease Research and Policy at the University of Chicago. "Researchers, hospitals and pharmaceutical ...
2021-02-03
UPTON, NY - Hundreds of naturally occurring specialty fatty acids (building blocks of oils) have potential for use as raw materials for making lubricants, plastics, pharmaceuticals, and more--if they could be produced at large scale by crop plants. But attempts to put genes for making these specialty building blocks into crops have had the opposite effect: Seeds from plants with genes added to make specialty fatty acids accumulated dramatically less oil. No one knew why.
Now two teams of biochemists working on separate aspects of oil synthesis at the U.S. Department of Energy's Brookhaven National Laboratory have converged to discover the mechanism behind the oil-production slowdown. As described in the journal Plant Physiology, they crossbred model plants and conducted detailed ...
LAST 30 PRESS RELEASES:
[Press-News.org] Intranasal influenza vaccine spurs strong immune response in Phase 1 study
